Immunosuppression and sebaceous tumors: a confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy

J Am Acad Dermatol. 2011 Nov;65(5):1054-1058.e1. doi: 10.1016/j.jaad.2010.08.003. Epub 2011 May 6.

Abstract

Muir-Torre syndrome (MTS) is an autosomal dominant genodermatosis caused by mutations in the DNA mismatch repair genes MLH1 and MSH2. This case describes a patient with an extensive family history of colon cancer who experienced the onset of multiple sebaceous adenomas and carcinomas after undergoing kidney transplantation and receiving immunosuppressive therapy. The finding of deficient MSH2 expression in the immunohistochemical analysis of a sebaceous carcinoma prompted genetic testing for a systemic mutation in the mismatch repair gene. A systemic mutation of the MSH2 gene was detected and, despite the absence of a visceral malignancy, the diagnosis of MTS was made. Immunosuppression has previously been thought to play a possible role in unmasking a latent MTS phenotype in transplant recipients, but systemic mutations have not previously been analyzed. The relationship between immunosuppression and sebaceous tumors with the possibility of unmasking a MTS phenotype in transplant recipients is discussed.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma, Sebaceous / etiology*
  • Adenocarcinoma, Sebaceous / genetics
  • Adenoma / etiology*
  • Adenoma / genetics
  • Carcinoma, Squamous Cell / etiology
  • Carcinoma, Squamous Cell / genetics
  • Codon, Nonsense
  • Colonic Neoplasms / diagnosis
  • Colonic Neoplasms / etiology
  • Colonic Neoplasms / genetics
  • Colonic Polyps / diagnosis
  • Colonic Polyps / etiology
  • Colonic Polyps / genetics
  • DNA Mismatch Repair
  • DNA Mutational Analysis
  • Facial Neoplasms / etiology
  • Facial Neoplasms / genetics
  • Graft vs Host Disease / prevention & control
  • Humans
  • Hypertension, Malignant / surgery
  • Immunosuppression Therapy*
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation
  • Male
  • Microsatellite Instability
  • Middle Aged
  • Muir-Torre Syndrome / diagnosis*
  • MutS Homolog 2 Protein / genetics*
  • Neoplasms, Multiple Primary / etiology*
  • Neoplasms, Multiple Primary / genetics
  • Phenotype
  • Skin Neoplasms / etiology*
  • Skin Neoplasms / genetics

Substances

  • Codon, Nonsense
  • Immunosuppressive Agents
  • MSH2 protein, human
  • MutS Homolog 2 Protein